Repligen Corp. (RGEN) announced that it has elected Alfred Goldberg to its board. Goldberg is currently a Professor of Cell Biology at Harvard Medical School. He was appointed an Assistant Professor at Harvard Medical School in 1969, immediately following one year as an Instructor. Goldberg has been a Professor at Harvard Medical School since 1977.
Goldberg has served as a consultant to many biotechnology and pharmaceutical companies and on numerous Scientific Advisory Boards including the Michael J. Fox Foundation, The American Foundation for Aging Research, The Gladstone Institute of Neurological Disease at The University of California Medical School, and The Center for Neurodegenerative Disease at Brigham and Women's Hospital to name a few.
For comments and feedback: editorial@rttnews.com